Skip to main content
. 2016 May 13;7(25):37882–37892. doi: 10.18632/oncotarget.9352

Table 1. Highest expansion clonocytes following decitabine therapy.

Patients AA Frequency
post pre
UPN1 CATAPGLSYEQYF 0.061386633 0.008880571
UPN2 CSASDHEQYF 0.043817388 0.015202491
UPN3 CASSSLTDLTSYEQYF 0.008112579 0.041222265
UPN4 CASSLSCS~LWGKEYF 0.007189667 2.47E-06